TNSN98120A1 - 5 - (2-ETHYLE - 2H-TETRAZOLE - 5YL) - 1 - METHYLE - 1,2,3,6 - TETRAHYDROPURIDINE. - Google Patents
5 - (2-ETHYLE - 2H-TETRAZOLE - 5YL) - 1 - METHYLE - 1,2,3,6 - TETRAHYDROPURIDINE.Info
- Publication number
- TNSN98120A1 TNSN98120A1 TNTNSN98120A TNSN98120A TNSN98120A1 TN SN98120 A1 TNSN98120 A1 TN SN98120A1 TN TNSN98120 A TNTNSN98120 A TN TNSN98120A TN SN98120 A TNSN98120 A TN SN98120A TN SN98120 A1 TNSN98120 A1 TN SN98120A1
- Authority
- TN
- Tunisia
- Prior art keywords
- ethyle
- tetrazole
- tetrahydropuridine
- methyle
- phrmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA PRESENTE INVENTION SE RAPPORTE A UN SEL D'ADDITION D'ACIDE MALEATE DE 5-(2-ETHYLE-2H- TETRAZOLE-5YL)-1-METHYLE-1,2,3,6- TETRAHYDROPYRIDINE, AUX COMPOSITIONS PHRMACEUTIQUES CONTENANT LE SEL D'ADDITION ACIDE ET L'UTILISATION DE CETTE SOURCE POUR LE TRAITEMENT DES TROUBLES PROVOQUES PAR LE DYSFONCTIONNEMENT DE L'ACETHYLCHOLINE (AcCH) OU DU SYSTEME MUSCARINIQUE.THE PRESENT INVENTION RELATES TO A MALEATE ACID ADDED SALT OF 5- (2-ETHYLE-2H- TETRAZOLE-5YL) -1-METHYL-1,2,3,6- TETRAHYDROPYRIDINE, TO PHRMACEUTICAL COMPOSITIONS CONTAINING SALT ACID ADDITION AND THE USE OF THIS SOURCE FOR THE TREATMENT OF DISORDERS CAUSED BY THE DYSFUNCTION OF ACETHYLCHOLINE (AcCH) OR THE MUSCARINIC SYSTEM.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN98120A1 true TNSN98120A1 (en) | 2005-03-15 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN98120A TNSN98120A1 (en) | 1997-07-01 | 1998-06-30 | 5 - (2-ETHYLE - 2H-TETRAZOLE - 5YL) - 1 - METHYLE - 1,2,3,6 - TETRAHYDROPURIDINE. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (en) |
| JP (1) | JP2002507215A (en) |
| KR (1) | KR20010014297A (en) |
| CN (1) | CN1261361A (en) |
| AR (1) | AR013096A1 (en) |
| AU (1) | AU735751B2 (en) |
| BG (1) | BG103933A (en) |
| BR (1) | BR9810331A (en) |
| CA (1) | CA2293324A1 (en) |
| CO (1) | CO4940483A1 (en) |
| EA (1) | EA200000081A1 (en) |
| HU (1) | HUP0002876A2 (en) |
| IL (1) | IL133093A0 (en) |
| IS (1) | IS5278A (en) |
| JO (1) | JO2031B1 (en) |
| MA (1) | MA25138A1 (en) |
| NO (1) | NO996580D0 (en) |
| PE (1) | PE116099A1 (en) |
| PL (1) | PL337184A1 (en) |
| SK (1) | SK187399A3 (en) |
| TN (1) | TNSN98120A1 (en) |
| TR (1) | TR199903283T2 (en) |
| UY (2) | UY25069A1 (en) |
| WO (1) | WO1999001448A1 (en) |
| ZA (1) | ZA985498B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| JPH11514654A (en) * | 1995-11-06 | 1999-12-14 | ハー・ルンドベック・アクチェゼルスカベット | How to treat brain injury due to trauma |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/en not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/en unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/en not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/en unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/en not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/en unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 CN CN98806497A patent/CN1261361A/en active Pending
- 1998-07-01 PL PL98337184A patent/PL337184A1/en unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/en unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/en not_active Application Discontinuation
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/en not_active Application Discontinuation
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 SK SK1873-99A patent/SK187399A3/en unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/en unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/en active Pending
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/en unknown
- 1998-07-01 EA EA200000081A patent/EA200000081A1/en unknown
- 1998-07-01 MA MA25155A patent/MA25138A1/en unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/en not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/en unknown
- 1999-11-30 BG BG103933A patent/BG103933A/en unknown
- 1999-12-30 NO NO996580A patent/NO996580D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200000081A1 (en) | 2000-08-28 |
| AU8102098A (en) | 1999-01-25 |
| PL337184A1 (en) | 2000-08-14 |
| HUP0002876A2 (en) | 2001-06-28 |
| MA25138A1 (en) | 2001-04-02 |
| WO1999001448A1 (en) | 1999-01-14 |
| IS5278A (en) | 1999-11-30 |
| AR013096A1 (en) | 2000-12-13 |
| NO996580L (en) | 1999-12-30 |
| UY25069A1 (en) | 1998-12-21 |
| ZA985498B (en) | 1999-01-20 |
| KR20010014297A (en) | 2001-02-26 |
| CO4940483A1 (en) | 2000-07-24 |
| SK187399A3 (en) | 2000-06-12 |
| NO996580D0 (en) | 1999-12-30 |
| BR9810331A (en) | 2000-09-05 |
| EP0994869A1 (en) | 2000-04-26 |
| TR199903283T2 (en) | 2000-06-21 |
| CA2293324A1 (en) | 1999-01-14 |
| UY25177A1 (en) | 2000-12-29 |
| BG103933A (en) | 2000-07-31 |
| IL133093A0 (en) | 2001-03-19 |
| JO2031B1 (en) | 1999-05-15 |
| CN1261361A (en) | 2000-07-26 |
| PE116099A1 (en) | 1999-11-23 |
| AU735751B2 (en) | 2001-07-12 |
| JP2002507215A (en) | 2002-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN98154A1 (en) | NOVEL 2-AMINOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| TNSN99110A1 (en) | NON-PEPTIDE INHIBITORS OF VLA-4 DEPENDENT CELL ADHESION, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| BG106771A (en) | Heterocyclic substituted pyrazolones | |
| TNSN01126A1 (en) | NOVEL SUBSTITUTED IMIDAZOLES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | |
| TNSN98104A1 (en) | PROSTAGLANDIN AGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| TNSN99039A1 (en) | BICYCLO [2.2.1] NEW HEPTANES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| TNSN99031A1 (en) | NOVEL HETEROCYCLIC COMPOUNDS INHIBITORS OF ROMATASES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| TNSN99006A1 (en) | 4- (2-CETO-1-BENZIMIDAZOLINYL) NOVEL PIPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MA32655B1 (en) | Compounds selectively modulating the cb2 receptor | |
| TNSN98084A1 (en) | DERIVATIVES OF SUBSTITUTED MACROLIDES IN POSITION C-4 | |
| FR2393573A1 (en) | HAIR PREPARATIONS CONTAINING A VINYLPYRROLIDONE COPOLYMER | |
| MA26697A1 (en) | NOVEL GSK-3 INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| TNSN99126A1 (en) | NOVEL PYRROLOPYRIMIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| TNSN98182A1 (en) | NOVEL PROSTAGLANDIN AGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| EP0786995A4 (en) | ||
| MA21072A1 (en) | PROCESS FOR THE PREPARATION OF A COMBINATION OF ANGIOTENSIN CONVERSION ENZYME INHIBITORS WITH CALCIUM ANTAGONISTS. | |
| MA28093A1 (en) | POLYMORPH FORM OF 3-PHENYLSULFONYL-8-PIPERAZINE-1-YL-QUINOLINE | |
| TNSN98227A1 (en) | PHARMACEUTICAL ASSOCIATION FOR THE TREATMENT OF SEXUAL DYSFUNCTION AND COMPOSITIONS CONTAINING SAME. | |
| TNSN99001A1 (en) | 2,3-SUBSTITUTED INDOLES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | |
| TNSN01046A1 (en) | DIPHENYL ETHERS USEFUL IN THERAPEUTICS | |
| TNSN96174A1 (en) | AZETIDINES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MA26741A1 (en) | NEW ZIPRASIDONE SUSPENSIONS AND PROCESS FOR THEIR PREPARATION. | |
| TNSN99013A1 (en) | NOVEL DIHYDROXYHEXANOIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| TNSN97039A1 (en) | DERIVATIVES OF OXADIAZOLE AND THIADIAZOLE ANTAGONISTS OF MUSCARINIC RECEPTORS. | |
| TNSN99056A1 (en) | NOVEL SUBSTITUTED AZABICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |